Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BMRN
Recent news which mentions BMRN
< Previous
1
2
3
4
5
6
7
8
Next >
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Tickers
ABCL
ADGI
AGIO
ARYD
Tags
SGMO
NVTA
Guidance
From
Benzinga
BioMarin Clocks Flat Q4 Sales Despite Erosion oF US Kuvan Market
February 24, 2022
Tickers
BMRN
SNY
Tags
Earnings
News
Health Care
From
Benzinga
Recap: Biomarin Pharmaceutical Q4 Earnings
February 23, 2022
Tickers
BMRN
Tags
Benzinga
BZI/Recaps
Earnings
From
Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Tickers
AKBA
ARNA
AVNS
BHC
Tags
FLGT
IBB
NUVA
From
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers
ABCL
AGIO
ARNA
ATXI
Tags
BHC
MRVI
NVRO
From
Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
February 18, 2022
Tickers
BMRN
Tags
BMRN
gene therapy
Benzinga
From
Benzinga
BioMarin Sells Priority Review Voucher For $110M
February 09, 2022
Tickers
BMRN
Tags
General
Benzinga
Biotech
From
Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
Tickers
ADGI
ALLK
ALNY
ARGX
Tags
ALNY
SPX
SAGE
From
MarketWatch
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
Hemophilia A
Market News
General
From
Benzinga
2 Under-the-Radar Biotech Picks to Buy For The Long Haul
December 24, 2021
Tickers
BMRN
CORT
CPRX
Tags
Recent Press Releases
BMRN
Market News
From
Motley Fool
This Favorable Sign Appears On Biomarin Pharmaceutical's Chart
November 25, 2021
Tickers
BMRN
Tags
Markets
BZI/CROSS
Movers
From
Benzinga
Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
November 24, 2021
Tickers
BMRN
Tags
BMRN
Market News
Benzinga
From
Benzinga
Where Biomarin Pharmaceutical Stands With Analysts
November 22, 2021
Tickers
BMRN
Tags
Market News
Benzinga
BMRN
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
November 22, 2021
Tickers
ADBE
AIP
ALNY
ASPU
Tags
STNE
TD
CE
From
Benzinga
10 Biggest Price Target Changes For Monday
November 22, 2021
Tickers
ALNY
AMGN
ATVI
BMRN
Tags
Market News
RDFN
ETSY
From
Benzinga
Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday
November 20, 2021
Tickers
BMRN
Tags
Market News
Recent Press Releases
BMRN
From
Motley Fool
FDA Conditionally Approves Biomarin's Dwarfism Drug
November 19, 2021
Tickers
BMRN
Tags
Benzinga
Market News
Health Care
From
Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
INCY
Market News
RHHBF
From
Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Tickers
ACRX
AMRN
ATHX
AYTU
Tags
PRPO
RMED
Benzinga
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
Tickers
AADI
AMYT
BMRN
BYSI
Tags
FDA
Top Stories
News
From
Benzinga
BioMarin's Q3 Net Income Hit By Lower Product Sales
October 28, 2021
Tickers
BMRN
Tags
Earnings
Briefs
News
From
Benzinga
BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
October 28, 2021
Tickers
BMRN
Tags
BMRN
Market News
From
Motley Fool
Biomarin Pharmaceutical: Q3 Earnings Insights
October 27, 2021
Tickers
BMRN
Tags
BMRN
Earnings
Market News
From
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Tickers
ABBV
ADAP
ALIM
ALKS
Tags
JNJ
MMSI
Market News
From
Benzinga
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
October 23, 2021
Tickers
BLUE
BMRN
BMY
JNJ
Tags
Market News
BMY
JNJ
From
Motley Fool
The Smartest Stocks to Buy With $250 Right Now
October 22, 2021
Tickers
BMRN
FRPT
GRWG
Tags
Market News
FRPT
GRWG
From
Motley Fool
Barron's Latest Picks And Pans: Amazon, Apple, Chevron, Citigroup, Dell And More
October 16, 2021
Tickers
AAPL
AMZN
BMRN
C
Tags
TDG
Media
C
From
Benzinga
Stifel Upgrades This Pharma Stock On Prospective FDA Approval For Dwarfism Drug
September 09, 2021
Tickers
BMRN
Tags
Price Target
Analyst Color
Health Care
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
Tickers
ALGS
AMRN
APEN
APP
Tags
PMT
ARVN
NPTN
From
Benzinga
Price To Earnings Ratio Insights For Biomarin Pharmaceutical
September 07, 2021
Tickers
BMRN
Tags
Markets
News
Intraday Update
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today